SERK3 Antibody

What is SERK3/BAK1 and what cellular functions does it perform?

SERK3/BAK1 is a leucine-rich repeat receptor-like kinase (LRR-RLK) that functions as a shape-complementary co-receptor for multiple plant signaling pathways. It contains an extracellular LRR domain, a transmembrane region, and an intracellular kinase domain essential for signal transduction. SERK3/BAK1 plays dual roles in:

• Brassinosteroid (BR) signaling through interaction with the BRI1 receptor for plant growth and development

• Plant immunity by associating with pattern recognition receptors (PRRs) like FLS2 that detect PAMPs

• Integration of diverse perception events into downstream PAMP responses, leading to immunity against invading microbes

SERK3/BAK1 primarily localizes to the plasma membrane but can also be found in endosomal compartments following receptor activation and internalization .

How does SERK3/BAK1 contribute to plant immunity?

SERK3/BAK1 serves as a central regulator of plant immune responses through several mechanisms:

• Functions as a co-receptor for multiple PRRs, including FLS2 (FLAGELLIN SENSING 2), which recognizes bacterial flagellin and its derivative flg22

• Rapidly enters elicitor-dependent complexes with these receptors upon PAMP detection

• Required for early immune responses to PAMPs, as demonstrated by greatly reduced immune responses in SERK3/BAK1-deficient plants

• Contributes significantly to resistance against specific pathogens - silencing NbSerk3 in Nicotiana benthamiana enhanced susceptibility to the oomycete Phytophthora infestans but did not affect resistance to P. mirabilis

• Regulates cell death responses triggered by pathogen-derived proteins like INF1

• Associates with receptor-like proteins (RLPs) such as Cf-4 and Cf-9 upon elicitation with matching effector ligands to initiate receptor endocytosis and plant immunity

What are optimal protocols for Western blot detection of SERK3/BAK1?

Based on published research, successful Western blot detection of SERK3/BAK1 requires:

• Sample preparation: Use extraction buffers containing 1% Triton X-100, protease inhibitors, and reducing agents (e.g., DTT)

• Protein separation: Employ 10% SDS-PAGE gels under reducing conditions

• Membrane selection: PVDF membranes have been successfully used for SERK3 detection

• Antibody concentration: 1 μg/mL of anti-SERK3/BAK1 monoclonal antibody

• Expected molecular weight: SERK3/BAK1 appears at approximately 59 kDa, with potential truncated fragments at ~48 kDa (C-terminal fragment)

• Detection systems: HRP-conjugated secondary antibodies with appropriate chemiluminescent substrates

Example procedure from published research:

• Extract proteins from plant tissue (e.g., 1g tissue ground in 3mL extraction buffer)

• Separate proteins on SDS-PAGE and transfer to membrane

• Block membrane and probe with anti-SERK3/BAK1 antibody (1 μg/mL)

• Apply HRP-conjugated secondary antibody (typically 1:5,000-1:10,000 dilution)

• Develop using appropriate detection reagents

How can immunoprecipitation with SERK3/BAK1 antibodies be optimized?

Effective immunoprecipitation of SERK3/BAK1 and its interacting partners requires:

Sample preparation:

• Extract proteins under mild conditions to preserve interactions (buffer example: 50 mM Bis-Tris pH 7.0, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 5 mM DTT, protease inhibitors)

• Use 20-50 mg total protein for adequate SERK3/BAK1 yield

Immunoprecipitation procedure:

• Incubate protein extracts with anti-SERK3/BAK1 antibodies (or anti-epitope tag antibodies for tagged versions)

• Capture antibody-protein complexes using magnetic beads or protein A/G matrices

• Wash extensively (4+ washes) to reduce nonspecific binding

• Elute bound proteins using SDS sample buffer at 95°C

Research has successfully used this approach to demonstrate interactions between SERK3/BAK1 and partners including BRI1, FLS2, and BIR proteins .

Table: Co-immunoprecipitation efficiency of SERK3 mutants with BIR3

Data adapted from research findings .

How can fluorescence microscopy be used to visualize SERK3/BAK1 localization and interactions?

Advanced imaging of SERK3/BAK1 utilizing antibody-based techniques includes:

Immunocytochemistry for colocalization studies:

• Fix and permeabilize plant tissues

• Label with primary antibodies against SERK3/BAK1 (or epitope tags like HA or GFP)

• Apply fluorophore-conjugated secondary antibodies (e.g., Alexa488, Alexa568)

• Image using confocal microscopy to assess protein localization

FRET-FLIM (Förster Resonance Energy Transfer-Fluorescence Lifetime Imaging):

• Label potential interaction partners with appropriate donor and acceptor fluorophores

• Measure changes in fluorescence lifetime as indicators of protein proximity

• This technique has successfully demonstrated BRI1-SERK3 interactions within specific membrane compartments

Table: Colocalization analysis of BRI1-GFP and SERK3-HA under different treatments

Data from research findings showing quantification of plasma membrane signal distribution and correlation between BRI1-GFP and SERK3-HA .

How can phosphorylation-specific antibodies be used to study SERK3/BAK1 activation?

Phospho-specific antibodies provide powerful tools for monitoring SERK3/BAK1 activation state:

• Generation of phospho-specific antibodies:

  • Develop antibodies against key phosphorylation sites (e.g., pY403)

  • Validate specificity using phosphorylation site mutants (Y403F)

• Applications:

  • Western blotting to detect phosphorylation status under different treatments or in various genetic backgrounds

  • Immunoprecipitation of active (phosphorylated) receptor pools

  • Immunolocalization to determine where activated receptors accumulate in cells

• Experimental validation:

  • Test antibody specificity against recombinant wild-type and mutant proteins

  • Assess cross-reactivity with related proteins

  • Use kinase-inactive mutants as negative controls

Research has demonstrated that Y403 phosphorylation is critical for SERK3/BAK1 immune function but not BR signaling, highlighting the value of phospho-specific detection tools .

How can one distinguish between different SERK family members in experimental systems?

Plants contain multiple SERK family members with partially overlapping functions. Differentiation strategies include:

Genetic approaches:

• Use specific T-DNA insertion mutants for each SERK gene

• Create higher-order mutants by crossing single knockouts

• Confirm genotypes by PCR and expression levels by RT-PCR using gene-specific primers

Antibody-based discrimination:

• Develop antibodies against unique epitopes in each SERK family member

• Validate specificity using corresponding knockout mutants

• For SERK3/BAK1, antibodies targeting the C-terminal peptide (DSTSQIENEYPSGPR) have proven successful

Cloning and sequencing:

• Amplify SERK genes using primers targeting unique regions

• Sequence analysis can distinguish between closely related family members

• In N. benthamiana, two SERK3 homologs (NbSerk3A and NbSerk3B) were identified through this approach

What factors influence the binding specificity of SERK3/BAK1 antibodies?

Several factors affect the specificity and performance of SERK3/BAK1 antibodies:

• Epitope selection:

  • Epitopes in highly conserved regions may cross-react with other SERK family members

  • C-terminal regions often provide better specificity due to greater sequence divergence

  • The epitope should be accessible in the folded protein for native applications

• Post-translational modifications:

  • Phosphorylation can mask epitopes or create new ones

  • Proteolytic processing generates truncated fragments (~48 kDa C-terminal fragment)

  • Glycosylation may affect antibody access to epitopes

• Sample preparation considerations:

  • Membrane proteins require appropriate detergents for extraction

  • Denaturing conditions may expose epitopes hidden in native proteins

  • Fixation methods for microscopy can alter epitope accessibility

• Controls for specificity validation:

  • Test antibodies on knockout/knockdown lines

  • Pre-incubate with blocking peptides to confirm specificity

  • Include related family members to assess cross-reactivity

How can SERK3/BAK1 antibodies be used to study receptor complex dynamics?

SERK3/BAK1 forms dynamic complexes with multiple receptors. Antibody-based approaches to study these dynamics include:

• Sequential co-immunoprecipitation:

  • First immunoprecipitate with antibodies against one receptor (e.g., BRI1)

  • Elute and perform second immunoprecipitation with anti-SERK3 antibodies

  • Analyze complex components by western blot or mass spectrometry

• Quantitative complex analysis:

  • Perform co-immunoprecipitation after various treatments (e.g., ligand application)

  • Quantify relative amounts of interacting partners by immunoblotting

  • Example: BL (brassinolide) treatment enhances BRI1-SERK3 association

• Competition studies:

  • Use analytical techniques like size-exclusion chromatography to study competition between receptors for SERK3/BAK1 binding

  • Research has shown that BIR2 can compete with BRI1 for SERK3 binding, but BIR2 cannot dissociate already formed BRI1-BL-SERK3 complexes

• Spatiotemporal analysis:

  • Track receptor complex formation and dissociation over time using microscopy

  • Measure changes in FRET efficiency as indicators of complex dynamics

  • Quantify receptor internalization following complex formation

How can mass spectrometry complement antibody-based studies of SERK3/BAK1?

Mass spectrometry provides powerful complementary approaches to antibody-based SERK3/BAK1 research:

• Phosphorylation site mapping:

  • Purify SERK3/BAK1 by immunoprecipitation using specific antibodies

  • Digest with proteases (e.g., trypsin and AspN) to generate peptide fragments

  • Analyze by LC-MS/MS using instruments like Orbitrap Fusion Trihybrid mass spectrometer

  • Identify phosphorylated residues through database searching and manual validation

• Interactome analysis:

  • Immunoprecipitate SERK3/BAK1 and associated proteins

  • Identify interaction partners by mass spectrometry

  • Quantify changes in the interactome following different treatments

• Protocol details:

  • Sample preparation: Proteins separated by SDS-PAGE, bands excised and digested

  • LC-MS/MS analysis: Performed with nanoflow-HPLC systems

  • Data analysis: Search against appropriate databases (e.g., TAIR10 for Arabidopsis)

  • Validation: Manual inspection of spectra and modified residue positions

Mass spectrometry has identified critical phosphosites in SERK3/BAK1, including Y403 and S612, that differentially affect immune versus growth signaling functions .

How do researchers interpret contradictory results between in vitro and in vivo SERK3/BAK1 studies?

Researchers face several interpretive challenges when in vitro and in vivo SERK3/BAK1 studies yield conflicting results:

What are the most significant methodological challenges when working with membrane receptor kinases like SERK3/BAK1?

Researchers face several technical challenges when studying membrane receptor kinases:

• Protein extraction and solubilization:

  • Membrane proteins require detergents for solubilization

  • Harsh detergents may disrupt protein-protein interactions

  • Optimal conditions must balance extraction efficiency with preservation of native complexes

• Receptor dynamics and trafficking:

  • Receptors move between different cellular compartments

  • Trafficking can be affected by experimental manipulations

  • Capturing transient interactions requires precise timing and techniques

• Post-translational modifications:

  • Phosphorylation status changes rapidly upon stimulation

  • Sample preparation may alter modification patterns

  • Phosphatase inhibitors are crucial during extraction

• Functional redundancy:

  • SERK family members show partial functional overlap

  • Higher-order mutants may be required to observe phenotypes

  • Generation of complete knockout sets is challenging due to lethality (e.g., serk1 serk2 bak1/serk3 triple mutants)

• Quantitative analysis:

  • Membrane protein abundance is often low

  • Signal-to-noise ratio challenges in imaging studies

  • Need for sophisticated quantification methods to detect subtle changes

Understanding these challenges is essential for designing robust experiments and correctly interpreting results in SERK3/BAK1 research.

How are new antibody technologies improving SERK3/BAK1 research?

Recent technological advances are enhancing antibody-based SERK3/BAK1 research:

• Single-domain antibodies (nanobodies):

  • Smaller size allows better access to epitopes in complex structures

  • Can be expressed intracellularly to track proteins in living cells

  • Potential to detect specific conformations of activated receptors

• Conformation-specific antibodies:

  • Designed to recognize specific activated or inactive receptor states

  • Help distinguish between different functional pools of SERK3/BAK1

  • Valuable for studying mechanisms of receptor activation

• Multiplexed detection systems:

  • Simultaneous visualization of multiple SERK family members

  • Combination of antibodies with different detection modalities

  • Enhanced spatial resolution through super-resolution microscopy techniques

• Antibody engineering strategies:

  • Recombinant antibody fragments with improved stability and specificity

  • Site-specific conjugation for precise labeling

  • Optimization for specific applications (Western blot, IP, microscopy)

These advances promise to provide new insights into SERK3/BAK1 biology and receptor kinase function in plants.

What methodological developments are needed to better understand SERK3/BAK1 phosphorylation dynamics?

Current limitations in studying SERK3/BAK1 phosphorylation dynamics could be addressed through:

• Improved temporal resolution:

  • Rapid sampling techniques to capture transient phosphorylation events

  • Synchronized receptor activation systems for population studies

  • Microfluidic approaches for precise ligand application

• Enhanced phosphosite specificity:

  • Development of additional phosphosite-specific antibodies

  • Multiplexed detection of multiple phosphorylation events

  • Targeted mass spectrometry methods for quantitative phosphopeptide analysis

• In situ phosphorylation detection:

  • Genetically encoded biosensors for specific phosphorylation events

  • Single-molecule techniques to track phosphorylation in living cells

  • Correlative light and electron microscopy to link phosphorylation with ultrastructure

• Mathematical modeling:

  • Kinetic models of receptor phosphorylation and signal propagation

  • Integration of quantitative experimental data

  • Prediction of system behavior under different conditions

• Protocol optimization for HDX-MS studies:

  • Hydrogen-deuterium exchange mass spectrometry to study conformational changes

  • Sample handling protocols that minimize deuterium back-exchange

  • Data analysis pipelines for complex membrane proteins